There is a newer version
of
this Statute
2019 Louisiana Laws
Revised Statutes
Title 22 - Insurance
§1060.4. Adverse determination
Universal Citation: LA Rev Stat § 22:1060.4 (2019)
RS 1060.4 - Adverse determination
A. The refusal of a health insurance issuer to provide benefits to an enrollee for a prescription drug is an adverse determination for purposes of the Internal Claims and Appeals Process and External Review Act, R.S. 22:2391 et seq., if each of the following conditions is met:
(1) The drug is not included in a drug formulary used by the health benefit plan.
(2) The enrollee's physician or other authorized prescriber has determined the drug is medically necessary.
B. The enrollee may appeal the adverse determination pursuant to the Internal Claims and Appeals Process and External Review Act, R.S. 22:2391 et seq.
Acts 2011, No. 350, §1, eff. Jan. 1, 2012; Acts 2016, No. 573, §1, eff. Jan. 1, 2017.
Disclaimer: These codes may not be the most recent version. Louisiana may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
